Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00239525 · ClinicalTrials.gov registry record · NA
3-D Transcranial Ultrasound Analysis Study
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT00239525 is a NA study that has completed, run by Duke University. The registered enrollment target is 28 participants.
The verdict
NCT00239525, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate real time 3-D ultrasound imaging of the brain for the diagnosis and evaluation of stroke.
Interventions
- DEVICE 3-D ultrasound scanner
- DRUG Perflutren Protein-Type A Microspheres for injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2006-05 |
| Est. Completion | 2013-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00239525
The ClinicalTrials.gov registry entry for NCT00239525 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 3-D ultrasound scanner is the first listed.
NCT00239525 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00239525 about?
NCT00239525 is a clinical study titled "3-D Transcranial Ultrasound Analysis Study". The purpose of this study is to investigate real time 3-D ultrasound imaging of the brain for the diagnosis and evaluation of stroke.
What is the current status of trial NCT00239525?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2006-05. Estimated completion is 2013-12.
What interventions are being tested in trial NCT00239525?
The interventions under investigation include: 3-D ultrasound scanner (DEVICE), Perflutren Protein-Type A Microspheres for injection (DRUG).
Who is sponsoring clinical trial NCT00239525?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.